OHR Pharmaceutical Company
OHR Pharmaceutical develops products for the treatment of cancer cachexia and wet age-related macular degeneration.
Founded Date:
2009
Last Funding Type:
Venture - Series Unknown
Headquarters:
New York, New York, United States
Investors Number:
1
Technology:
Small Molecules
Employee Number:
1-10
Industry:
PharmTech
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Total Funding:
$3M